Paul Wengender

Paul is Founder & CEO of Crows Nest Biosciences (Worcester, MA). He has more than two decades of experience in creation, managing, and successful commercialization of business projects in the field of biotechnology. From 2015 to 2017 he served as a Chef Business officer at Beryllium Discovery (Medford, MA), and from 2015 to 2014 as a Chief Strategist (Executive-In-Residence) of Strategia Therapeutics, Inc. (Boston, MA). Earlier (2003-2016) he founded and led Blue Sky BioTech (Worcester, MA, now Lake Pharma), a preclinical Contract Research Organization (CRO). During this period Paul gradually built Blue Sky team from 2 to 45 employees. Mr. Wengender will advise ZATA in the development and licensing medical product and drug candidates enabling by ZATA’s platform technologies.